Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

covid 19 vaccine

What Can Possibly Explain WHO's Delay In Approving Covaxin?
What Can Possibly Explain WHO's Delay In Approving Covaxin?Bhaswati Guha Majumder Oct 20, 2021 07:16 PM +05:30 IST
New Zealand Will Continue To Use Pfizer-BioNTech Jab Despite Woman's Death Linked To The Vaccine
New Zealand Will Continue To Use Pfizer-BioNTech Jab Despite Woman's Death Linked To The VaccineBhaswati Guha Majumder Aug 30, 2021 07:03 PM +05:30 IST
Are Covid-19 Booster Shots Helpful? Here's What Israel's Study Says
Are Covid-19 Booster Shots Helpful? Here's What Israel's Study Says Bhaswati Guha Majumder Aug 23, 2021 01:34 PM +05:30 IST
Covid-19 Vaccines For Children Expected By September, Says AIIMS Chief
Covid-19 Vaccines For Children Expected By September, Says AIIMS ChiefBhaswati Guha Majumder Jul 24, 2021 03:34 PM +05:30 IST
Over 60 Per Cent Indians Have Covid-19 Antibodies But 40 Crore Are Still Vulnerable: ICMR
Over 60 Per Cent Indians Have Covid-19 Antibodies But 40 Crore Are Still Vulnerable: ICMR Bhaswati Guha Majumder Jul 21, 2021 02:11 PM +05:30 IST
Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder
Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder Bhaswati Guha Majumder Jul 14, 2021 06:42 PM +05:30 IST
Zydus Cadila's Covid-19 Vaccine For Kids May Get Emergency Approval This Week
Zydus Cadila's Covid-19 Vaccine For Kids May Get Emergency Approval This WeekBhaswati Guha Majumder Jul 12, 2021 07:57 PM +05:30 IST
AIIMS Director Says Not Much Data To Claim Delta Plus Is More Infectious And Cause More Deaths
AIIMS Director Says Not Much Data To Claim Delta Plus Is More Infectious And Cause More DeathsBhaswati Guha Majumder Jul 2, 2021 01:10 PM +05:30 IST
Singapore Concerned About Sinovac Covid-19 Vaccine After Hundreds Of Indonesian Healthcare Workers Tests Positive 
Singapore Concerned About Sinovac Covid-19 Vaccine After Hundreds Of Indonesian Healthcare Workers Tests Positive Bhaswati Guha Majumder Jun 21, 2021 01:26 PM +05:30 IST
Novavax Covid-19 Vaccine Is About 90 Per Cent Effective, Finds Large Study
Novavax Covid-19 Vaccine Is About 90 Per Cent Effective, Finds Large StudyBhaswati Guha Majumder Jun 14, 2021 05:40 PM +05:30 IST
Russia Tests Covid-19 Nasal Spray Vaccine For Children
Russia Tests Covid-19 Nasal Spray Vaccine For ChildrenBhaswati Guha Majumder Jun 14, 2021 04:20 PM +05:30 IST
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine  
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine  Bhaswati Guha Majumder Jun 7, 2021 08:02 PM +05:30 IST
Explained: China’s ‘PR’ Strategy To Vaccinate The World With Less Effective Covid-19 Jabs 
Explained: China’s ‘PR’ Strategy To Vaccinate The World With Less Effective Covid-19 Jabs Bhaswati Guha Majumder Jun 7, 2021 06:55 PM +05:30 IST
Brazil Approves Covaxin For Import, WHO Approval 'Will Be Achieved Soon'
Brazil Approves Covaxin For Import, WHO Approval 'Will Be Achieved Soon'Bhaswati Guha Majumder Jun 5, 2021 02:15 PM +05:30 IST
Chinese Military Scientist Filed Patent For A Vaccine Soon After China Revealed Covid-19 Details in 2020 
Chinese Military Scientist Filed Patent For A Vaccine Soon After China Revealed Covid-19 Details in 2020 Bhaswati Guha Majumder Jun 5, 2021 01:55 PM +05:30 IST
India’s Increased Covid-19 Vaccine Manufacturing Capacity May Prove ‘Game-Changer’, Says US
India’s Increased Covid-19 Vaccine Manufacturing Capacity May Prove ‘Game-Changer’, Says USBhaswati Guha Majumder Jun 4, 2021 04:57 PM +05:30 IST
Booster Or No Booster: Scientists Explain Why World May Not Need Yearly Covid-19 Jabs 
Booster Or No Booster: Scientists Explain Why World May Not Need Yearly Covid-19 Jabs Bhaswati Guha Majumder Jun 4, 2021 01:34 PM +05:30 IST
Chinese Covid-19 Vaccine Maker  Sinopharm Publishes Most Awaited Study Details, Concerns About Trials Remain
Chinese Covid-19 Vaccine Maker Sinopharm Publishes Most Awaited Study Details, Concerns About Trials RemainBhaswati Guha Majumder Jun 3, 2021 03:19 PM +05:30 IST
Cipla Seeks Centre’s Support Ahead Of Committing Over $1 Billion For Moderna’s Covid-19 Booster Vaccine
Cipla Seeks Centre’s Support Ahead Of Committing Over $1 Billion For Moderna’s Covid-19 Booster VaccineBhaswati Guha Majumder Jun 1, 2021 07:23 PM +05:30 IST
Shankar Balasubramanian: Indian-Origin Chemist In Millennium Tech Prize-Winning Team For Revolutionary DNA Sequencing Tech
Shankar Balasubramanian: Indian-Origin Chemist In Millennium Tech Prize-Winning Team For Revolutionary DNA Sequencing TechBhaswati Guha Majumder May 19, 2021 08:02 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype